Atlas Trials

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Clinical trial NCT04729972 · COMPLETED

Trial details

NCT number
NCT04729972
Sponsor
Neurotech Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Macular Telangiectasia Type 2
Start date
2021-07-21
Primary completion
2022-12-08
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.